Im Ellie Eunkyung
Chief Medical Officer
Im Ellie Eunkyung has filed 3 SEC Form 4 filings (4 transaction rows) across 1 company, with disclosures dating back to 2025. 3 of those filings fall inside the rolling window. Most recent filing: Sep 18, 2026.
On the most recent filing, Im Ellie Eunkyung is listed as Chief Medical Officer at CRESCENT BIOPHARMA, INC. Inside the rolling window, Im Ellie Eunkyung reported no open-market purchases and 2 open-market sales totaling $33K in CBIO. The largest disclosed transaction in the window is a sale of 1,219 CBIO shares on Jun 22, 2026, worth $22K.
Companies traded
Other insiders at CBIO
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$33K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Im Ellie Eunkyung made?
Im Ellie Eunkyung has filed 3 SEC Form 4 filings (4 transaction rows) across 1 company since 2025.
Which companies does Im Ellie Eunkyung trade?
Im Ellie Eunkyung has filed SEC Form 4 disclosures for 1 company, including CBIO.
When was Im Ellie Eunkyung's most recent SEC Form 4 filing?
Im Ellie Eunkyung's most recent SEC Form 4 filing on Tracefour is dated Sep 18, 2026.
What is Im Ellie Eunkyung's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Im Ellie Eunkyung is listed as Chief Medical Officer.
What is Im Ellie Eunkyung's total buy and sell value in the current window?
Inside the rolling retention window, Im Ellie Eunkyung bought $0 and sold $33K based on SEC Form 4 filings.
What was Im Ellie Eunkyung's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 1,219 CBIO shares on 2026-06-22, worth $22K, per SEC Form 4 filings.